HALO vs LLY
HALO vs LLY — side by side. Price, change, valuation.
HALO
Halozyme Therapeutics, Inc.
$81.48−0.55%
NasdaqGS
LLY
Eli Lilly and Company
$1,197.53+0.13%
NYQ
| Metric | HALO | LLY | Side by side |
|---|---|---|---|
| Last price | $81.48 | $1,197.53 | −1,116.05 |
| Day Δ % | -0.55 | 0.13 | −0.67pp |
| Market cap | not on file | not on file | not on file |
| P/E (trailing) | not on file | not on file | not on file |
| Implied move | not on file | not on file | not on file |
| Put/Call OI | not on file | not on file | not on file |
| Analyst target (mean) | not on file | not on file | not on file |
Descriptor deltas are comparative facts (higher / lower), not a recommendation. A metric absent for either company is shown as “not on file” — never filled with a placeholder.